VITRAKVI HARD CAPSULE 100MG
Product details
Registration number: SIN15991P
Classification: Prescription Only
Active ingredients: Larotrectinib sulfate eqv larotrectinib
Strength: 100mg
Dosage form: CAPSULE
Route: ORAL
Registrant: BAYER (SOUTH EAST ASIA) PTE LTD
ATC code: L01EX12
HSA approval date: 17 August 2020
Manufacturer(s):
- Penn Pharmaceutical Services Limited (Bulk Production and Primary Packager)
- NextPharma Ploermel (Bulk Production)
Manufacturing country/countries: FRANCE; UNITED KINGDOM
What are the HSA registration number and classification for VITRAKVI HARD CAPSULE 100MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15991P
Classification: Prescription Only
What active ingredients and strength are recorded for VITRAKVI HARD CAPSULE 100MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Larotrectinib sulfate eqv larotrectinib
Strength: 100mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for VITRAKVI HARD CAPSULE 100MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE
Route: ORAL
Who is the recorded registrant for VITRAKVI HARD CAPSULE 100MG?
According to the HSA dataset updated 7 August 2026:
Registrant: BAYER (SOUTH EAST ASIA) PTE LTD
Which manufacturers and countries are listed for VITRAKVI HARD CAPSULE 100MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Penn Pharmaceutical Services Limited (Bulk Production and Primary Packager)
- NextPharma Ploermel (Bulk Production)
Manufacturing country/countries: FRANCE; UNITED KINGDOM
Where can I look up VITRAKVI HARD CAPSULE 100MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15991P or the exact product name VITRAKVI HARD CAPSULE 100MG. The general register link does not preselect this product.
What are the source dates for this VITRAKVI HARD CAPSULE 100MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this VITRAKVI HARD CAPSULE 100MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15991P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)